Evidence map›Paper›PMID 20375331›Full record

ArticleInvestigative ophthalmology & visual science2010

A quantitative rabbit model of vaccinia keratitis.

Sharon Altmann, Andrew Emanuel, Megan Toomey, Kim McIntyre, Jill Covert, Richard Redd Dubielzig, Gary Leatherberry, Christopher J Murphy, Shantha Kodihalli, Curtis R Brandt

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. A Pilot Study to Evaluate Genipin inInternational journal of molecular sciences · 2023
    Article
  8. Article
  9. Predatory Bacteria can ReducebioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Bacterial Keratitis:Current eye research · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sharon AltmannDepartment of Medical Microbiology and ImmunologyUniversity of Wisconsin-Madison, Madison, WI 53706, USA.
Andrew Emanuel
Megan Toomey
Kim McIntyre
Jill Covert
Richard Redd Dubielzig
Gary Leatherberry
Christopher J Murphy
Shantha Kodihalli
Curtis R Brandt
University of Wisconsin–Madison · US

Funding

UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI Donna M Peters · 2005 to 2026
$12.6M
NEI NIH HHS P30 EY016665PHS HHS AGRDTD 05/09/07
6 · The paper itself

Abstract

purposeThe goal of this study was to use multiple quantitative disease measures to evaluate the effect of various viral inocula on the development of vaccinia keratitis in rabbits.

methodsTrephined eyes of female rabbits were infected with 10(4), 10(5), 10(6), or 10(7) plaque-forming units (pfu) of the Dryvax strain of the vaccinia virus and scored daily for disease for 14 days according to a modification of the MacDonald-Shadduck scoring system. Ocular viral titers and vaccinia-specific antibody titers were determined by plaque assay and ELISA, respectively.

resultsThe amount of virus used for infection affected the severity of disease, with 10(4) pfu eliciting milder keratitis after delayed onset compared with higher amounts of virus. At inocula above 10(5) pfu the course and severity of corneal disease was not significantly different. The time to reach peak titers was delayed in the 10(4) group but peak titers were similar in all groups. Severe conjunctival chemosis interfered with scoring in animals infected with 10(6) or 10(7) pfu. Virus-specific antibody titers were similar in all groups at day 14. Body weights decreased less than 10% in all groups.

conclusionsThe course of vaccinia keratitis in rabbits paralleled that in humans. A viral inoculum of 10(5) pfu/eye was determined to be optimal for use in further studies of vaccinia keratitis.

Indexed as

Disease Models, AnimalRabbitsAnimalsAntibodies, ViralBody WeightChlorocebus aethiopsFemaleKeratitisLipSeverity of Illness IndexSkin UlcerSmallpox VaccineVacciniaVaccinia virusVero CellsAntibodies, ViralSmallpox Vaccine

Identifiers

PMID20375331
PMCPMC2941171
OpenAlexW1980229665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.